%PDF-1.4
%
1 0 obj
<>stream
application/pdf
10.1080/17512433.2020.1702878
en
JAK inhibition in the treatment of alopecia areata – a promising new dawn?
Fathima Ferial Ismail
Rodney Sinclair
Taylor & Francis
Expert Review of Clinical Pharmacology, 2020. doi:10.1080/17512433.2020.1702878
Alopecia areata
Janus kinase inhibitors
tofacitinib
ruxolitinib
baricitinib
CTP-543
PF-06651600
PF-06700841
Journal
Expert Review of Clinical Pharmacology
© 2019 Informa UK Limited, trading as Taylor & Francis Group
1751-2433
1751-2441
00
00
1
9
10.1080/17512433.2020.1702878
https://doi.org/10.1080/17512433.2020.1702878
VoR
2019-12-11T03:44:30+05:30
Arbortext Advanced Print Publisher 11.0.3433/W Unicode
2019-12-28T11:03:04-08:00
2019-12-28T11:03:04-08:00
Alopecia areata; Janus kinase inhibitors; tofacitinib; ruxolitinib; baricitinib; CTP-543; PF-06651600; PF-06700841
iText 4.2.0 by 1T3XT
uuid:5dd5a84a-91a0-45ee-b542-c1317f9ead2f
uuid:03bbba12-9a9a-4ef4-85d5-4edf6f2d4846
2019-12-22truewww.tandfonline.com10.1080/17512433.2020.1702878www.tandfonline.comtrue2019-12-2210.1080/17512433.2020.1702878
endstream
endobj
4 0 obj
<>stream
xXKo7BQo0-ڦ=-K~IhfώI}:9
IqCMtxzsTaSDzjPy- 3=Ocw&UCn+(]]ͻ.&*I:.{//iD;N|眞 .ryKC{oMHfREp7j(A,ܙ *ճ(wK_4x*Q#ϥU<6 x~yj2iYAT@{?Uzy<M;`|8sl}-OSOCOB4"B?B,ӻDW3S-H#6&l&forfvEv3RoƿT%"_K/rV"-
Ŗh/֛ \<ӈ @s_4p^ށ(^\71>BsCuє3d[&
D ПI2*4|}F_e½NY-:e5nPC2H' Ps?QŇ,y&K~bq^PVlدIEf>B?j݈C_/MˇG݆Bdb5D+m%GKI)3GuRz$W[6O$mvׂDSoK*gQ-ATD T-Hd)u(74mrPo|k.=ppUK_Cg[o瀝78b2\>/; :Ӕ$F'UT+5R$^(0Ykc4Uy_*0*+qWJH{V\Bˆ2!KRiY[2U_uۧVceOHthV.#
>OBo 1
,s(ZuoRޓb˅b3Ǽ$F5iq$km|dJ/.^RK4
endstream
endobj
24 0 obj
<>stream
xwXSsN`$!l{@ ٢ $@TR)XZԉ(
RZD|y L0V@(#q `= nnWXX0+Зȕ;ѫ R1{Ol (Lγx\䜙/V'LKP0RX~@9k(8u?̰yBOΑr y
<)_Έ"<?_l)
F+s9H
MI #~__ Q$.R$sŅg%f,a6GTLΟEQԖ!/Bſ)EogEA?l kJ^-ؒ \?l{ P&d\EAt{6~/ÇfJq2bFn6g0<8aO"yD|TyE